Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,031.60
(
-2.05%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.69
(
1.01%
)
Bitcoin
68,563.32
(
-0.32%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: ghmm post# 130795

Friday, 11/18/2011 12:55:22 PM

Friday, November 18, 2011 12:55:22 PM

Post# of 257295
FOLD - I'm not too sure how reliable crowley is based on all the clinical milestones that have been missed but if the Amigal trial is positive he may look to sell the company. A potential catalyst this quarter is the ERT+Amigal PII interim trial results.

http://www.bloomberg.com/news/2010-12-22/amicus-open-to-future-glaxo-bid-if-fabry-drug-succeeds-in-study.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today